India to Guatemala: Diclofenac Export Trade Route
India has recorded 92 verified shipments of Diclofenac exported to Guatemala, representing a combined trade value of $2.2M USD. This corridor is served by 11 active Indian exporters, with an average shipment value of $24.1K USD. The leading Indian exporter is CAPLIN POINT LABORATORIES LIMITED, which accounts for 77% of total export value with 58 shipments worth $1.7M USD. On the buying side, NUEVOS ETICOS NEOETHICALS S A is the largest importer in Guatemala with $880.4K USD in purchases. The top 3 suppliers — CAPLIN POINT LABORATORIES LIMITED, UMEDICA LABORATORIES PRIVATE LIMITED, ARGUS SALUD PHARMA LLP — together control 96% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Guatemala Diclofenac corridor is one of India's established pharmaceutical export routes, with 92 shipments documented worth a combined $2.2M USD. The route is dominated by CAPLIN POINT LABORATORIES LIMITED, which alone accounts for roughly 77% of all export value, reflecting the consolidated nature of India's diclofenac manufacturing sector.
Across 11 active suppliers, the average shipment value stands at $24.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with diclofenac's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 18.8%, placing it at rank #20 among India's top diclofenac export destinations globally.
On the import side, key buyers of Indian diclofenac in Guatemala include NUEVOS ETICOS NEOETHICALS S A, NUEVOS ETICOS NEOETHICALS, S.A., FARMA SOLUTION SOCIEDAD ANONIMA and 16 others. NUEVOS ETICOS NEOETHICALS S A is the single largest importer with 26 shipments valued at $880.4K USD.
Route Characteristics
- Average transit25 days
- Peak seasonQ1
- Primary modeSea freight
- Top portCHENNAI SEA (INMAA1)
Market Position
- Global rank#20
- Annual growth+18.8%
- Demand growth+17.9%
- Regulatory ease88/100
Top 10 Indian Diclofenac Exporters to Guatemala
Showing top 10 of 11 Indian suppliers exporting Diclofenac to Guatemala, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CAPLIN POINT LABORATORIES LIMITED Avg $29.6K per shipment | 58 | $1.7M | 77.5% |
| 2 | UMEDICA LABORATORIES PRIVATE LIMITED Avg $63.2K per shipment | 5 | $315.8K | 14.3% |
| 3 | ARGUS SALUD PHARMA LLP Avg $31.3K per shipment | 3 | $94.0K | 4.2% |
| 4 | UMEDICA LABORATORIES PVT LTD Avg $29.9K per shipment | 1 | $29.9K | 1.3% |
| 5 | TROIKAA PHARMACEUTICALS LIMITED Avg $6.0K per shipment | 4 | $23.9K | 1.1% |
| 6 | S3K IMPEX PRIVATE LIMITED Avg $22.8K per shipment | 1 | $22.8K | 1.0% |
| 7 | BALAXI VENTURES LIMITED Avg $2.4K per shipment | 2 | $4.7K | 0.2% |
| 8 | AASHIRWAD PHARMA INTERNATIONAL PRIVATE LIMITED Avg $1.0K per shipment | 4 | $4.2K | 0.2% |
| 9 | 3S CORPORATION Avg $589 per shipment | 4 | $2.4K | 0.1% |
| 10 | SUNNY PHARMA Avg $120 per shipment | 6 | $718 | 0.0% |
This table shows the top 10 of 11 Indian companies exporting diclofenac to Guatemala, ranked by total trade value. The listed exporters are: CAPLIN POINT LABORATORIES LIMITED, UMEDICA LABORATORIES PRIVATE LIMITED, ARGUS SALUD PHARMA LLP, UMEDICA LABORATORIES PVT LTD, TROIKAA PHARMACEUTICALS LIMITED, S3K IMPEX PRIVATE LIMITED, BALAXI VENTURES LIMITED, AASHIRWAD PHARMA INTERNATIONAL PRIVATE LIMITED, 3S CORPORATION, SUNNY PHARMA. CAPLIN POINT LABORATORIES LIMITED is the dominant supplier with 58 shipments worth $1.7M USD, giving it a 77% market share. The top 3 suppliers together account for 96% of the total trade value on this route.
Showing top 10 of 11 total Indian exporters on the India to Guatemala Diclofenac export route.
Top 10 Diclofenac Importers in Guatemala
Showing top 10 of 19 known buyers in Guatemala receiving Diclofenac shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian diclofenac in Guatemala include NUEVOS ETICOS NEOETHICALS S A, NUEVOS ETICOS NEOETHICALS, S.A., FARMA SOLUTION SOCIEDAD ANONIMA, CORPORACION UMED S A, CORPORACION UMED, S.A., among 19 total buyers. The largest importer is NUEVOS ETICOS NEOETHICALS S A, accounting for $880.4K USD across 26 shipments — representing 40% of all diclofenac imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NUEVOS ETICOS NEOETHICALS S A | 26 | $880.4K | 39.8% |
| 2 | NUEVOS ETICOS NEOETHICALS, S.A. | 23 | $641.0K | 28.9% |
| 3 | FARMA SOLUTION SOCIEDAD ANONIMA | 9 | $260.1K | 11.7% |
| 4 | CORPORACION UMED S A | 3 | $171.9K | 7.8% |
| 5 | CORPORACION UMED, S.A. | 1 | $72.9K | 3.3% |
| 6 | CORPORACION UMED S A O AMERICA NIT | 1 | $67.7K | 3.1% |
| 7 | CORPORACION UMED, SA, | 1 | $33.1K | 1.5% |
| 8 | NUEVOS ETICOS NEOETHICALS S.A. | 2 | $25.3K | 1.1% |
| 9 | PROFON, S.A. | 1 | $22.8K | 1.0% |
| 10 | DISTRIBUCION DE | 2 | $12.4K | 0.6% |
Showing top 10 of 19 Diclofenac importers in Guatemala on this route.
Top 10 Diclofenac Formulations Imported by Guatemala
Showing top 10 of 54 product formulations shipped on the India to Guatemala Diclofenac route, ranked by trade value
Guatemala imports a wide range of diclofenac formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — DICLOFENAC SODIUM + NEUROTROPAS SOFT GEL — accounts for $341.4K USD across 4 shipments. There are 54 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DICLOFENAC SODIUM + NEUROTROPAS SOFT GEL | 4 | $341.4K | 15.4% |
| 2 | DICLOFENAC SODIUM AND NEUROTROPAS SOFT GELATIN CAPSULES | 6 | $274.8K | 12.4% |
| 3 | DICLOFENAC POTASSIUM TABLETS USP 50MG | 8 | $260.4K | 11.8% |
| 4 | DICLOFENAC POTASSIUM TABLETS USP 50 MG | 7 | $215.8K | 9.7% |
| 5 | DICLOFENAC SODIUM + NEUROTROPAS SOFT GELATIN CAPSULES | 2 | $152.1K | 6.9% |
| 6 | 1. DICLOFENAC SODIUM INJECTION 75MG/3ML. | 2 | $142.0K | 6.4% |
| 7 | DICLOFENAC SODIUM INJECTION 75MG/3ML. (BOX OF 1X10 AMPOULES) | 1 | $72.9K | 3.3% |
| 8 | (DICLOFENAC SODIUM SOFT GELATIN CAPSULES50MG) DICLO ROJO | 1 | $69.8K | 3.2% |
| 9 | DICLOFENAC SODIUM INJECTION 75MG/3ML.BOX OF 1X10 AMPOULES | 1 | $67.7K | 3.1% |
| 10 | DICLO ROJO ( DICLOFENAC SODIUM SOFT GELATIN CAPSULES 50 MG ) | 3 | $54.3K | 2.5% |
Showing top 10 of 54 Diclofenac formulations imported by Guatemala on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 84%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
CHENNAI SEA (INMAA1) handles the highest volume with 21 shipments. Transit time averages 25 days by sea.
Market Dynamics
India's diclofenac exports to Guatemala are driven primarily by a handful of large-scale manufacturers. CAPLIN POINT LABORATORIES LIMITED with 58 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in Guatemala benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CAPLIN POINT LABORATORIES LIMITED, UMEDICA LABORATORIES PRIVATE LIMITED, ARGUS SALUD PHARMA LLP — together account for 96% of total trade value on this route. The average shipment value of $24.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as diclofenac sodium and neurotropas soft gelatin capsules and diclofenac potassium tablets usp 50mg, suggesting that buyers in Guatemala tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, NUEVOS ETICOS NEOETHICALS S A is the largest importer with 26 shipments worth $880.4K USD — representing 40% of all diclofenac imports from India on this route. A total of 19 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.2M
- Avg. Shipment
- $24.1K
- Suppliers
- 11
- Buyers
- 19
- Transit (Sea)
- ~25 days
- Annual Growth
- +18.8%
Related Analysis
Other Diclofenac Routes
Unlock the Full India to Guatemala Diclofenac Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 92 shipments on this route.
Frequently Asked Questions — India to Guatemala Diclofenac Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Diclofenac to Guatemala?
The leading Indian exporters of Diclofenac to Guatemala are CAPLIN POINT LABORATORIES LIMITED, UMEDICA LABORATORIES PRIVATE LIMITED, ARGUS SALUD PHARMA LLP. CAPLIN POINT LABORATORIES LIMITED holds the largest market share at approximately 77% of total trade value on this route.
Q What is the total value of Diclofenac exports from India to Guatemala?
India exports Diclofenac to Guatemala worth approximately $2.2M USD across 92 recorded shipments. The average value per shipment is $24.1K USD.
Q Which ports does India use to ship Diclofenac to Guatemala?
The most active port of origin is CHENNAI SEA (INMAA1) with 21 shipments. Indian exporters primarily use sea freight for this route, with 84% of shipments going by sea and 29% by air.
Q How long does shipping take from India to Guatemala for Diclofenac?
The average transit time for Diclofenac shipments from India to Guatemala is approximately 25 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Guatemala Diclofenac trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 18.8% with demand growth tracking at 17.9%. The route is ranked #20 among India's top Diclofenac export destinations globally.
Q How many suppliers are active on the India to Guatemala Diclofenac route?
There are currently 11 active Indian suppliers exporting Diclofenac to Guatemala. The market is moderately concentrated with CAPLIN POINT LABORATORIES LIMITED accounting for 77% of total shipment value.
Q Who are the main importers of Diclofenac from India in Guatemala?
The leading importers of Indian Diclofenac in Guatemala include NUEVOS ETICOS NEOETHICALS S A, NUEVOS ETICOS NEOETHICALS, S.A., FARMA SOLUTION SOCIEDAD ANONIMA, CORPORACION UMED S A, CORPORACION UMED, S.A.. NUEVOS ETICOS NEOETHICALS S A is the largest buyer with 26 shipments worth $880.4K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Guatemala export trade corridor identified from Indian Customs (DGFT) records for Diclofenac.
- 2.Supplier/Buyer Matching: 11 Indian exporters and 19 importers in Guatemala matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 92 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
92 Verified Shipments
11 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists